PIN1 accelerates APP cis-to-trans isomerization, thus favoring the non-amyloidogenic pathway, while, in the absence of PIN1, APP is processed through the amyloidogenic pathway, thus predisposing an individual to AD. This evidence concerns the gene PIN1 and Alzheimer disease.